NCT02221154终止4 期
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
适应症
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 49
- 试验地点
- 8
- 主要终点
- Incidence of OHSS in each group, graded mild, moderate or severe based on the recommendations
研究概览
简要总结
The original mechanism of action of myo-inositol and preliminary results available in the literature on its use in IVF suggest its value as adjuvant gonadotropin therapy to reduce the risk of OHSS in PCOS patients.
The aim of the study is to demonstrate that administration of myo-inositol decreases the incidence of ovarian hyperstimulation syndrome (OHSS) in high-risk infertile with PCOS supported in IVF patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 38 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients PCOS (Rotterdam ESHRE / ASRM criteria)
- •Combination of at least two of the following three criteria:
- •Cycle disorder
- •Clinical hyperandrogenism and / or biological
- •Account antral follicles> 24
- •Age ≤ 18 ≤ 38 years
- •BMI <35 kg / m²
- •Able to understand the protocol and signed informed consent
排除标准
- •Patients not having the Rotterdam criteria
- •Patients> 38 years and / or BMI> 35 kg / m²
- •Woman enjoying a measure of legal protection
- •Hypersensitivity to any component of the Inofolic (myo-inositol, soy, folic acid, glycerol, gelatin, coloring E171)
- •Participation in another interventional biomedical research with treatment administered may disrupt ovarian stimulation
结局指标
主要结局
Incidence of OHSS in each group, graded mild, moderate or severe based on the recommendations
时间窗: 3 month
次要结局
未报告次要终点
研究者
研究点 (8)
Loading locations...
相似试验
进行中（未招募）
不适用
Effect of the combined treatment with myo-inositol and metformin on the phenotype of the polycystic ovary syndrome: a pilot study - UOE/08/03polycystic ovary syndromeMedDRA version: 12.0Level: LLTClassification code 10036049Term: Polycystic ovariesEUCTR2008-006991-31-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
招募中
不适用
MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with Polycystic Ovary Syndrome: a multicentre double-blind randomised controlled trialPolycystic ovary syndrome, Polycysteus ovarium syndroom, PCOSPregnancy complications, zwangerschapscomplicatiesNL-OMON28285Erasmus MC, University Medical Center Rotterdam464
尚未招募
4 期
Effect of a dietary supplement Myo-inositol for treating high sugar levels during pregnancyCTRI/2018/05/013937AIIMS New Delhi
尚未招募
4 期
Efficacy of Myo-inositol in PCOS patientsCTRI/2024/06/068972Amrita Institute Of Medical Science
已完成
4 期
Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing In Vitro Fertilization CyclesSperm QualityOligoasthenospermiaNCT01560065AGUNCO Obstetrics and Gynecology Centre